跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Triamax - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Triamax
Approved
STANDARD
Triamax
Reyoung Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
9b1c9e10b2160258
Company
Reyoung Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
9b1c9e10b2160258
Drug Approval Philippines Name
Triamax
Product Name
Triamax
Registration Number
DRP-15551
Brand Name
Triamax
Generic Name
Ceftriaxone (as sodium)
Dosage Form
Powder for Injection
Dosage Strength
1 g
Manufacturer
Reyoung Pharmaceutical Co., Ltd.
Importer
Dreamax Incorporated
Distributor
Dreamax Incorporated
Issuance Date
31 July 2024
Expiry Date
01 August 2029
Pharmacologic Category
Antibacterial (Third-generation cephalosporin)
Classification
Prescription (Rx) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
9b1c9e10b2160258
Type
Standard
Back to Philippines FDA Approvals